UMIN-CTR Clinical Trial

Recruitment status Completed
Unique ID issued by UMIN UMIN000012196
Receipt No. R000013206
Official scientific title of the study The Study on HElicobacter Pylori eradication in patients with HEPatic complications
Date of disclosure of the study information 2019/03/31
Last modified on 2016/11/09 (Ver. 2)

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information
Official scientific title of the study The Study on HElicobacter Pylori eradication in patients with HEPatic complications
Title of the study (Brief title) HepHep Study
Region
Japan

Condition
Condition Chronic liver diseases
H. pylori infection
Classification by specialty
Medicine in general Gastroenterology Hepato-biliary-pancreatic medicine
Classification by malignancy Others
Genomic information NO

Objectives
Narrative objectives1 To clarify whether eradication of H. pylori in patients with chronic liver disease affects the hepatic complications such as thrombocytopenia and hyperammonemia
Basic objectives2 Safety,Efficacy
Basic objectives -Others
Trial characteristics_1
Trial characteristics_2
Developmental phase

Assessment
Primary outcomes Changes in platelet counts after eradication of H. pylori
Key secondary outcomes Changes in blood ammonia levels after eradication of H. pylori

Base
Study type Interventional

Study design
Basic design Single arm
Randomization Non-randomized
Randomization unit
Blinding Open -no one is blinded
Control Uncontrolled
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment

Intervention
No. of arms 1
Purpose of intervention Treatment
Type of intervention
Medicine
Interventions/Control_1 Patients will orally receive triple therapy with 30mg lansoprazole, 750mg amoxicillin, and 250mg clarithromycin twice a day for seven days
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

Eligibility
Age-lower limit

Not applicable
Age-upper limit

Not applicable
Gender Male and Female
Key inclusion criteria 1. Patients with chronic liver diseases
2. Patients with hepatic complications such as thrombocytopenia and hyperammonemia
3. Patients with H. pylori-related atrophic gastritis other upper gastrointestinal diseases diagnosed endoscopy
Key exclusion criteria 1. Patients with history of hypersensitivity to lansoprazole, amoxicillin, and clarithromycin.
2. Patients being treated with atazanavir, rilpivirine, pimozide, preparation containing ergotamine and tadalafil.
3. Patients with liver or kidney diseases being treated with colchicine.
4. Patients with infectious mononucleosis.
5. Patients with severe renal impairment.
6. Woman during the first three months of pregnancy.
7. Patients whom the principal and/or sub-investigators judged inadequate.
Target sample size 30

Research contact person
Name of lead principal investigator Masaru Enomoto
Organization Osaka City University Graduate School of Medicine
Division name Department of Hepatology
Address 1-4-3 Asahimachi, Abeno-ku, Osaka 545-8585, Japan
TEL 06-6645-3811
Email enomoto-m@med.osaka-cu.ac.jp

Public contact
Name of contact person Masaru Enomoto
Organization Osaka City University Graduate School of Medicine
Division name Department of Hepatology
Address 1-4-3 Asahimachi, Abeno-ku, Osaka 545-8585, Japan
TEL 06-6645-3811
Homepage URL
Email enomoto-m@med.osaka-cu.ac.jp

Sponsor
Institute Osaka City University Graduate School of Medicine
Institute
Department

Funding Source
Organization None
Organization
Division
Category of Funding Organization Self funding
Nationality of Funding Organization

Other related organizations
Co-sponsor
Name of secondary funder(s)

Secondary IDs
Secondary IDs NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions

Other administrative information
Date of disclosure of the study information
2019 Year 03 Month 31 Day

Progress
Recruitment status Completed
Date of protocol fixation
2013 Year 08 Month 05 Day
Anticipated trial start date
2013 Year 08 Month 05 Day
Last follow-up date
Date of closure to data entry
Date trial data considered complete
Date analysis concluded

Related information
URL releasing protocol
Publication of results Unpublished
URL releasing results
Results
Other related information

Management information
Registered date
2013 Year 11 Month 01 Day
Last modified on
2016 Year 11 Month 09 Day


Link to view the page
URL(English) https://upload.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000013206